- Home
- MREO vs TMQ Comparison
MREO vs TMQ Comparison
Compare MREO & TMQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- TMQ
- Stock Information
- Founded
- MREO 2015
- TMQ 2004
- Country
- MREO United Kingdom
- TMQ Canada
- Employees
- MREO N/A
- TMQ N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- TMQ Precious Metals
- Sector
- MREO Health Care
- TMQ Basic Materials
- Exchange
- MREO Nasdaq
- TMQ Nasdaq
- Market Cap
- MREO 281.6M
- TMQ 249.6M
- IPO Year
- MREO N/A
- TMQ N/A
- Fundamental
- Price
- MREO $1.76
- TMQ $2.07
- Analyst Decision
- MREO Strong Buy
- TMQ
- Analyst Count
- MREO 5
- TMQ 0
- Target Price
- MREO $7.40
- TMQ N/A
- AVG Volume (30 Days)
- MREO 932.9K
- TMQ 506.3K
- Earning Date
- MREO 11-11-2025
- TMQ 10-07-2025
- Dividend Yield
- MREO N/A
- TMQ N/A
- EPS Growth
- MREO N/A
- TMQ N/A
- EPS
- MREO N/A
- TMQ N/A
- Revenue
- MREO $500,000.00
- TMQ N/A
- Revenue This Year
- MREO N/A
- TMQ N/A
- Revenue Next Year
- MREO $55.50
- TMQ N/A
- P/E Ratio
- MREO N/A
- TMQ N/A
- Revenue Growth
- MREO N/A
- TMQ N/A
- 52 Week Low
- MREO $1.47
- TMQ $0.47
- 52 Week High
- MREO $4.72
- TMQ $2.19
- Technical
- Relative Strength Index (RSI)
- MREO 48.66
- TMQ 65.66
- Support Level
- MREO $1.68
- TMQ $2.04
- Resistance Level
- MREO $1.88
- TMQ $2.19
- Average True Range (ATR)
- MREO 0.07
- TMQ 0.13
- MACD
- MREO 0.01
- TMQ 0.03
- Stochastic Oscillator
- MREO 45.45
- TMQ 80.95
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About TMQ Trilogy Metals Inc.
Trilogy Metals Inc is an exploration stage company engaged in mineral exploration. The company focuses on exploring and developing its mineral resource properties, which include the Upper Kobuk Mineral Projects (UKMP or UKMP Projects), in the Ambler mining district located in Alaska, the United States. Its properties include the Arctic copper-zinc-gold-silver project and other mineralized targets within a volcanogenic massive sulfide belt, and it also has a bornite carbonate-hosted copper project.